Amlexanoxum [Latin] en es it fr

Amlexanoxum [Latin] Brand names, Amlexanoxum [Latin] Analogs

Amlexanoxum [Latin] Brand Names Mixture

  • No information avaliable

Amlexanoxum [Latin] Chemical_Formula


Amlexanoxum [Latin] RX_link

No information avaliable

Amlexanoxum [Latin] fda sheet

Amlexanoxum_[Latin] FDA

Amlexanoxum [Latin] msds (material safety sheet)

Amlexanoxum_[Latin] MSDS

Amlexanoxum [Latin] Synthesis Reference

No information avaliable

Amlexanoxum [Latin] Molecular Weight

298.293 g/mol

Amlexanoxum [Latin] Melting Point

No information avaliable

Amlexanoxum [Latin] H2O Solubility

No information avaliable

Amlexanoxum [Latin] State


Amlexanoxum [Latin] LogP


Amlexanoxum [Latin] Dosage Forms

Oral paste (5%, 5g)

Amlexanoxum [Latin] Indication

Used as a paste in the mouth to treat aphthous ulcers (canker sores).

Amlexanoxum [Latin] Pharmacology

Amlexanox is a mucoadhesive oral paste which has been clinically proven to abort the onset, accelerate healing and resolve the pain of aphthous ulcers (canker sores). It decreases the time ulcers take to heal. Because amlexanox decreases the healing time, it also decreases the pain you feel. Recent studies have also shown that the majority of ulcers can be prevented by application of the paste during the prodromal (pre-ulcerative) phase of the disease. Recurrent Aphthous Ulcers (RAU) also known as Recurrent Aphthous Stomatitis (RAS) is recognized as the most common oral mucosal disease known to man. Estimates suggest that 20% - 25% of the general population suffer at least one incidence of aphthous ulcers each year.

Amlexanoxum [Latin] Absorption

No significant absorption directly through the active ulcer. Most of the systemic absorption is via the gastrointestinal tract.

Amlexanoxum [Latin] side effects and Toxicity

No information avaliable

Amlexanoxum [Latin] Patient Information

Amlexanoxum [Latin] Organisms Affected

Humans and other mammals